Biotech Firm BillionToOne Shares Surge 67% on $273M IPO
Molecular-diagnostics startup BillionToOne raised $273 million in an oversubscribed IPO, with shares jumping 67% at debut and valuing the company at around $4.4 billion.
You are viewing the comprehensive archive for articles tagged with "billiontoone stocks". Our editorial team provides essential coverage, in-depth analysis, and real-time market data across all critical topics impacting the global economy. This section compiles the most relevant news, research, and expert commentary to help you navigate the trends and forces shaping the financial world. Stay informed with MarketSpeaker to ensure your knowledge is current and comprehensive.
Molecular-diagnostics startup BillionToOne raised $273 million in an oversubscribed IPO, with shares jumping 67% at debut and valuing the company at around $4.4 billion.